Your Skin Health
Journey Starts Here 피부 건강 여정이
여기서 시작됩니다

The human body is home to trillions of microorganisms, collectively known as the microbiome. These microscopic communities, residing on the skin and in the gut, play a crucial role in our health, particularly in modulating the immune system. Recent scientific research has shed light on the intricate relationship between the microbiome and atopic dermatitis (AD), a chronic inflammatory skin condition.

A consistent finding across multiple studies is that individuals with atopic dermatitis exhibit an imbalance, or "dysbiosis," in both their skin and gut microbiomes. This dysbiosis is characterized by a decrease in microbial diversity and an overgrowth of certain pathogenic bacteria, most notably Staphylococcus aureus. As highlighted by Paller et al. (2019), the reduction in microbial diversity on the skin of AD patients is directly correlated with the severity of the disease. This is further supported by Kim et al. (2019), who noted that AD patients have a disturbed microbial composition and lack microbial diversity in both their skin and gut compared to healthy individuals.

The "gut-skin axis" is a concept that has gained significant attention in understanding atopic dermatitis. This bidirectional communication pathway between the gut and the skin means that an unhealthy gut microbiome can influence skin health. Fang et al. (2021) explain that gut dysbiosis can lead to a compromised intestinal barrier, allowing inflammatory substances to enter the bloodstream and trigger or worsen skin inflammation. This systemic effect underscores the importance of a healthy gut in managing atopic dermatitis.

Topical Steroid Withdrawal (TSW) is a condition that can occur after discontinuing long-term use of topical steroids. Research by Maskey et al. (2025) indicates that a significant number of individuals going through TSW experience secondary bacterial infections, often characterized by a heavy colonization of S. aureus and notable alterations in the skin microbiome. This suggests that the skin microbiome is a critical factor in the TSW process.

The promising news is that these findings are opening doors to new therapeutic strategies. Hou et al. (2025) discuss the potential of using microbial signatures as predictive biomarkers for AD and the promise of novel treatments like probiotics and microbiota transplantation to restore a healthy microbial balance. Probiotics can help restore intestinal function and reshape the gut microbiome, potentially alleviating AD symptoms. Similarly, the topical application of beneficial commensal bacteria has shown promise in reducing AD severity by combating the overgrowth of S. aureus.

Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by dry, itchy, and inflamed skin. The health of the skin barrier is crucial in AD, and it is highly sensitive to environmental factors. For many years, patients and clinicians have suspected a link between water and eczema, specifically concerning the hardness of domestic water and the role of hydration.

Multiple studies have identified an association between living in a hard water area and the prevalence of atopic dermatitis. Hard water is defined by its high concentration of minerals, primarily calcium and magnesium. An influential study by McNally et al. (1998) was among the first to systematically investigate this link, finding a significantly higher prevalence of eczema in children living in areas with harder water. More recently, Lopez et al. (2022) using data from the UK Biobank confirmed this association in adults, finding that higher domestic hard water concentrations were associated with an increased prevalence of eczema in middle-aged adults.

How does hard water affect the skin? Research points to its impact on the skin barrier. The skin surface is naturally acidic, which is essential for its barrier function. Hard water is alkaline and can disrupt this natural acidity. A key study by Danby et al. (2018) demonstrated that washing with hard water increases the deposition of harsh surfactants, such as sodium lauryl sulphate (SLS), on the skin. The calcium in hard water binds to the surfactant, creating a residue that is difficult to rinse off and is particularly irritating to the skin.

While external factors are important, the role of internal hydration cannot be overlooked. A review by Douladiris et al. (2023) concluded that while topical moisturizers remain the first-line treatment for dry skin in AD, adequate dietary water intake does contribute to better skin hydration, especially in individuals who typically have low water consumption.

The Softened Water Eczema Trial (SWET) by Thomas et al. (2011), a large randomized controlled trial, enrolled 336 children with moderate to severe eczema. Surprisingly, the results showed no statistically significant difference in eczema severity between the water softener group and the control group. This suggests that while hard water is associated with a higher risk of eczema, installing a water softener is not an effective treatment for children who already have the condition. A systematic review by Jabbar-Lopez et al. (2021) further confirmed these findings.

The relationship between air quality and atopic dermatitis (AD) has garnered significant scientific interest. A growing body of evidence demonstrates a clear association between exposure to air pollutants and the development and exacerbation of AD. Air pollution is a complex mixture of particulate matter (PM), volatile organic compounds (VOCs), gases such as nitrogen dioxide (NO2), sulfur dioxide (SO2), and carbon monoxide (CO), as well as ozone (O3).

A comprehensive 2023 review by Fadadu et al. synthesized evidence from molecular to population-level studies, concluding that air pollution is a significant environmental risk factor for AD. At the molecular level, pollutants like PM2.5 and polycyclic aromatic hydrocarbons (PAHs) can activate the aryl hydrocarbon receptor (AhR) pathway in skin cells. Activation of this pathway leads to increased production of pro-inflammatory cytokines and oxidative stress, both of which are central to the pathology of AD.

Epidemiological studies have provided population-level evidence for this link. A large-scale national population-based retrospective cohort study by Park et al. (2022) found that exposure to air pollution was significantly associated with the incidence of atopic dermatitis in the general population. The study tracked millions of individuals and found a dose-response relationship: higher pollution levels correlated with a greater risk of developing AD.

Even patients on effective treatments are not immune to the effects of air pollution. A study by Bellinato et al. (2023) found that short-term exposure to environmental air pollution could trigger AD flares in patients being treated with dupilumab, a potent biologic therapy. This highlights the pervasive nature of air pollution as a trigger.

A 2024 review by Kim et al. in JAMA Network Open provided clinical recommendations, suggesting that clinicians should advise patients to monitor air quality indices and take protective measures on high-pollution days. The review also emphasized the need for public health policies aimed at reducing air pollution to protect vulnerable populations, including those with atopic dermatitis.

While conventional treatments like topical corticosteroids are effective for atopic dermatitis, they can have side effects with long-term use. This has led to a growing interest in complementary therapies, particularly those derived from plants. Phytochemicals, the bioactive compounds found in plants, have gained significant attention for their potential to manage AD symptoms due to their anti-inflammatory, antioxidant, and immunomodulatory properties.

Many phytochemicals, such as flavonoids and polyphenols, are potent antioxidants. They can neutralize reactive oxygen species (ROS), which are unstable molecules that contribute to inflammation and cellular damage in the skin. By reducing oxidative stress, phytochemicals can help protect skin cells and alleviate the inflammatory cascade that drives AD symptoms (Sharma et al., 2020).

Furthermore, phytochemicals exhibit significant anti-inflammatory effects. They can inhibit the production and activity of pro-inflammatory cytokines, such as interleukins (IL-4, IL-5, IL-13) and tumor necrosis factor-alpha (TNF-α). For instance, quercetin, a flavonoid found in many fruits and vegetables, has been shown to suppress the release of these inflammatory mediators from immune cells like mast cells and T-cells (Zawawi et al., 2025).

Some phytochemicals also play a role in strengthening the skin barrier. Certain compounds can promote the production of proteins like filaggrin, which is essential for maintaining the integrity of the stratum corneum. A stronger skin barrier is better able to retain moisture and protect against external triggers (Radhakrishnan et al., 2024).

A systematic review of Asian herbal medicine for atopic dermatitis by Limantara et al. (2023) found that while many traditional remedies show promise, more rigorous clinical trials are needed. However, several studies have reported positive outcomes with chamomile, calendula, and licorice root extract. A comprehensive 2025 review by Thakur et al. emphasized the potential of various phytochemicals, including berberine, piperine, and kaempferol, as safe and effective complementary therapies for AD.

The skin serves as a critical protective barrier against the external environment. In individuals with atopic dermatitis, this barrier is often compromised due to genetic factors (like filaggrin mutations) and inflammation, making it more permeable. The concept of "transdermal toxins" or Gyeongpidok (경피독)—the absorption of harmful chemicals through the skin—has gained increasing attention as a potential trigger and exacerbating factor for AD and TSW.

As Thyssen et al. (2014) noted, the impaired barrier function in AD patients increases their susceptibility to contact sensitization from ingredients commonly found in topical skincare products and metals. Everyday personal care products can be a significant source of chemical exposure.

A 2024 review by Lin et al. highlighted that many cosmetics, lotions, and cleansers contain potentially toxic ingredients, including endocrine-disrupting chemicals (EDCs) like parabens, phthalates, and bisphenols. These substances can be absorbed through the skin and have been associated with worsening dermatological conditions, including atopic dermatitis. The review underscores the importance of being aware of these pollutants to better manage the disease.

Research by Puangpet et al. (2013) presented cases where individuals with a history of childhood AD that had resolved experienced a clear reactivation of their eczema after repeated occupational or cosmetic chemical exposure. This suggests that for those with an atopic predisposition, sustained contact with certain chemicals can trigger the underlying inflammatory pathways even after years of remission.

Groundbreaking research from NIAID (Zeldin et al., 2023) identified a strong association between environmental exposure to diisocyanates—chemicals used in polyurethane production—and higher rates of eczema. The study uncovered a potential mechanism: when exposed to isocyanates, the beneficial bacteria on the skin alter their metabolism and stop producing the essential lipids that maintain a healthy skin barrier. This provides a direct molecular link between a common environmental pollutant and the disruption of skin homeostasis.

Beyond synthetic chemicals, biological toxins also play a crucial role. Park et al. (2017) reviewed the pathogenetic effect of toxins produced by Staphylococcus aureus, noting that these bacterial toxins act as superantigens, provoking a strong inflammatory response and further damaging the skin barrier.

Psychological stress is a well-established trigger and exacerbating factor for atopic dermatitis (AD). The relationship between stress and AD is rooted in a complex interplay of psychological, neurological, endocrine, and immune system interactions—a field known as psychoneuroimmunology.

The connection between the mind and the skin in AD is bidirectional. Not only can stress worsen AD symptoms, but the physical discomfort, visible lesions, and social stigma associated with AD can also be a significant source of psychological distress, creating a vicious cycle. Research by Courtney & Su (2024) has shown that individuals with AD have a higher risk of developing mental health conditions such as anxiety and depression. The chronic inflammation characteristic of AD can directly impact the brain, as pro-inflammatory cytokines can cross the blood-brain barrier and trigger neuroinflammation.

The primary mechanism through which stress impacts AD is by dysregulating the body's stress response system, the hypothalamic-pituitary-adrenal (HPA) axis. In many patients with AD, the HPA axis response is blunted or impaired (Lin et al., 2017). When faced with a stressor, their bodies may not produce enough cortisol to effectively counteract the inflammatory response, leading to a flare-up or worsening of their eczema.

Beyond the HPA axis, stress also activates the peripheral nervous system. Sensory nerve fibers in the skin release neuropeptides, such as substance P and calcitonin gene-related peptide (CGRP), which can directly act on immune cells, particularly mast cells, causing them to release histamine and other inflammatory mediators (Suárez et al., 2012).

Patient experiences corroborate these biological findings. A focus group study by Lönndahl et al. (2023) revealed that patients perceive stress-induced eczema as more severe and more difficult to treat than eczema triggered by other factors. Common psychological triggers reported include work overload, financial problems, school exams, and unforeseen life events.

The psychological impact is particularly pronounced in Topical Steroid Withdrawal (TSW). Studies by Brookes et al. (2023) and Alsterholm et al. (2025) have found a high prevalence of anxiety, depression, and even suicidal ideation among individuals going through TSW. Many patients report feeling dismissed by healthcare professionals, compounding their psychological burden.

While the visible symptoms of atopic dermatitis are well-known, a less visible but equally significant aspect is its profound impact on sleep. Research consistently shows that a large percentage of individuals with AD experience significant sleep disturbances. The connection between AD and sleep is often described as a "vicious cycle"—a bidirectional relationship where eczema disrupts sleep, and poor sleep worsens eczema.

A 2018 review by Chang and Chiang highlights this two-way street, suggesting that sleep disorders should be considered a comorbidity of AD rather than just a symptom. The primary way AD disrupts sleep is through the relentless sensation of pruritus (itching), which often intensifies at night, leading to difficulty falling asleep, frequent awakenings, and reduced overall sleep quality.

A comprehensive 2021 review by Bawany et al. notes that sleep disturbances affect a staggering 47-80% of children and 33-90% of adults with AD. A 2020 study by Alomayri et al. found a direct correlation between the severity of AD symptoms and poorer sleep quality, as measured by the Pittsburgh Sleep Quality Index (PSQI).

Conversely, a lack of restorative sleep can have a detrimental effect on atopic dermatitis. Sleep deprivation is known to disrupt the body's immune system, potentially leading to increased inflammation. It can also impair the skin's natural barrier function, making it more susceptible to irritants and allergens.

The consequences extend far beyond fatigue. A 2015 US population-based study by Silverberg et al. found that adults with eczema had significantly higher odds of experiencing fatigue, regular daytime sleepiness, and insomnia. This was linked to poorer overall health, more sick days, and more frequent doctor visits. In children, Camfferman et al. (2010) revealed that behavioral issues often seen in children with eczema—such as hyperactivity and oppositional behavior—are not a direct result of the skin condition itself but are mediated through the sleep disturbances it causes.

This section presents a real-world case study based on a meticulously maintained atopy recovery journal spanning 17 months (August 2018 – December 2019). The journal contains 1,072 symptom records, daily water intake logs, and lifestyle observations. This data provides a rare, longitudinal view into the lived experience of managing atopic dermatitis and the recovery process.

The individual documented their symptoms daily, tracking affected body areas, symptom types, water consumption, and use of foot baths (a traditional hydrotherapy method). This level of detail allows us to identify patterns, seasonal trends, and correlations that are often missed in clinical settings. The analysis below is entirely based on this real data, with all product names removed for legal reasons.

One of the most striking findings is the clear seasonal pattern. Symptom records peaked dramatically during winter months (October–March), with January and March 2019 each recording 132 entries. In contrast, summer months showed significantly fewer records, with June 2019 having only 19 entries. This aligns with established research showing that cold, dry air exacerbates atopic dermatitis by compromising the skin barrier.

The data also reveals a gradual improvement trajectory. While the early months (September–October 2018) were dominated by acute symptoms like redness, swelling, and oozing, later records increasingly mention improvement indicators such as "skin becoming smoother," "redness subsiding," and "less dryness." Out of all records, 72 entries noted improvement while only 5 entries noted worsening, suggesting an overall positive recovery trend.

Water intake was consistently tracked, with an average daily consumption of 2.5 liters (range: 1.4–3.5L). This disciplined hydration practice aligns with research showing that adequate water intake supports skin barrier function. Additionally, 66 foot bath sessions were recorded, reflecting a commitment to complementary hydrotherapy approaches.

This section analyzes the nutritional supplement protocol used during the 17-month atopy recovery journey. Rather than focusing on specific product brands, we examine the active ingredients and their scientific rationale for skin health and immune modulation. The data reveals a systematic, multi-layered approach targeting gut health, anti-inflammation, detoxification, and skin barrier repair.

The protocol evolved over time: an intensive phase (months 1–4) with daily supplementation, followed by a stabilization phase (months 5–9) with consistent use, and finally a maintenance phase (months 10–17) with reduced frequency as symptoms improved. This gradual tapering reflects a responsive, data-driven approach to supplementation.

The core strategy centered on five key pillars: probiotics for gut-skin axis support, B-vitamins for cellular metabolism and skin regeneration, omega-3 fatty acids for anti-inflammatory action, silymarin (milk thistle) for liver detoxification, and beta-carotene for skin barrier strengthening. These five ingredients were maintained consistently throughout the entire 15–16 month period.

Complementary ingredients were added strategically: dietary fiber for gut microbiome support, calcium/magnesium for immune regulation, vitamin C (acerola) for antioxidant protection, and comprehensive multivitamins for nutritional completeness. Hydrotherapy through foot baths (114 sessions) and consistent water intake (avg. 2.5L/day) complemented the oral supplementation.